Thangavelu, Govindarajan
Andrejeva, Gabriela http://orcid.org/0000-0002-3508-7682
Bolivar-Wagers, Sara
Jin, Sujeong
Zaiken, Michael C.
Loschi, Michael http://orcid.org/0000-0002-4460-5939
Aguilar, Ethan G.
Furlan, Scott N.
Brown, Chrysothemis C.
Lee, Yu-Chi
Hyman, Cameron McDonald
Feser, Colby J.
Panoskaltsis-Mortari, Angela
Hippen, Keli L.
MacDonald, Kelli P.
Murphy, William J. http://orcid.org/0000-0002-2793-401X
Maillard, Ivan http://orcid.org/0000-0003-1312-6748
Hill, Geoffrey R.
Munn, David H.
Zeiser, Robert
Kean, Leslie S.
Rathmell, Jeffrey C.
Chi, Hongbo http://orcid.org/0000-0002-9997-2496
Noelle, Randolph J.
Blazar, Bruce R.
Funding for this research was provided by:
National Heart and Lung Institute (R01 HL56067)
Article History
Received: 12 September 2021
Accepted: 14 April 2022
First Online: 17 May 2022
Competing interests
: BB receives remuneration as an advisor to Kamon Pharmaceuticals, Five Prime Therapeutics, Regeneron Pharmaceuticals, Magenta Therapeutics, and BlueRock Therapeuetics; research support from Fate Therapeutics, RXi Pharmaceuticals, Alpine Immune Sciences, Abbvie, the Leukemia and Lymphoma Society, the Children’s Cancer Research Fund, and the KidsFirst Fund and is a cofounder of Tmunity. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.